|
Alloimmune lymphocytes proliferation in presence of Mixed Lymphocyte Culture and cyclosporine
|
S. Milani    , F. Yari |
|
|
| Keywords: Cyclosporin A, Lymphocyte Culture test٬ Mixed, Blood Transfusion |
|
|
Full-Text [PDF 649 kb]
(693 Downloads)
| Abstract (HTML) (1699 Views)
|
Type of Study: Research |
Subject:
Imunology
Published: 2021/07/1
|
|
|
|
|
|
|
Full-Text: (1553 Views) |
References:
- Pissas G, Eleftheriadis T. Assessment of Humoral Alloimmunity in Mixed Lymphocyte Reaction. Bio Protoc 2019; 9(2): e3139.
- Bodmer W. Ruggero Ceppellini: A Perspective on His Contributions to Genetics and Immunology. Front Immunol 2019; 10: 1280.
- Eleftheriadis T, Pissas G, Sounidaki M, Antoniadi G, Antoniadis N, Liakopoulos V, et al. Uric acid increases cellular and humoral alloimmunity in primary human peripheral blood mononuclear cells. Nephrology (Carlton). 2018; 23(7): 610-5.
- Murphy WJ. Raising the spectra of T-cell profiling. Blood 2008; 112(8): 3008-9.
- Revenfeld ALS, Bæk R, Jørgensen MM, Varming K, Stensballe A. Induction of a Regulatory Phenotype in CD3+ CD4+ HLA-DR+ T Cells after Allogeneic Mixed Lymphocyte Culture; Indications of Both Contact-Dependent and -Independent Activation. Int J Mol Sci 2017; 18(7): 1603.
- Fischbacher D, Merle M, Liepert A, Grabrucker C, Kroell T, Kremser A, et al. Cytokine Release Patterns in Mixed Lymphocyte Culture (MLC) of T-Cells with Dendritic Cells (DC) Generated from AML Blasts Contribute to Predict anti-Leukaemic T-Cell Reactions and Patients' Response to Immunotherapy. Cell Commun Adhes 2015; 22(2-6): 49-65.
- Pino-Lagos K, Michea P, Sauma D, Alba A, Morales J, Bono MR, et al. Cyclosporin A-treated dendritic cells may affect the outcome of organ transplantation by decreasing CD4+CD25+ regulatory T cell proliferation. Biol Res 2010; 43(3): 333-7.
- Hilchey SP, Palshikar MG, Emo JA, Li D, Garigen J, Wang J, et al. Cyclosporine a directly affects human and mouse b cell migration in vitro by disrupting a hIF-1 αdependent, o2 sensing, molecular switch. BMC Immunol 2020; 21(1): 13.
- Donjerković D, Scott DW. Activation-induced cell death in B lymphocytes. Cell Res 2000; 10(3): 179-92.
- Schleker T, Jacobsen EM, Mayer B, Strauss G, Debatin KM, Posovszky C. Preserved in vitro immunoreactivity in children receiving long-termimmunosuppressive therapy due to inflammatory bowel disease or autoimmune hepatitis. Mol Cell Pediatr 2018; 5(1): 1.
- de Almeida R, Nakamura CN, de Lima Fontes M, Deffune E, Felisbino SL, Kaneno R, et al. Enhanced immunization techniques to obtain highly specific monoclonal antibodies. MAbs 2018; 10(1): 46-54.
- Hamilton JR, Westhoff CM, Kell K. Kidd Blood Group Systems in Transfusion Medicine and Hemostasis. Philadelphia: Elsevier; 2019. p. 157-61.
- Chonat S, Arthur CM, Zerra PE, Maier CL, Jajosky RP, Yee MEM, et al. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion. Transfus Clin Biol 2019; 26(2): 130-4.
- Pandey H, Das SS, Chaudhary R. Red cell alloimmunization in transfused patients: A silent epidemic revisited. Asian J Transfus Sci 2014; 8(2): 75-7.
- Amoli MM, Carthy D, Platt H, Ollier WE. EBV Immortalization of human B lymphocytes separated from small volumes of cryo-preserved whole blood. Int J Epidemiol 2008; 37 Suppl 1: i41-5.
- Weng NP. Telomere and adaptive immunity. Mech Ageing Dev 2008; 129(1-2): 60-6.
- Lemskaya NA. A modified protocol for highly efficient EBV-mediated immortalization of human B lymphocytes from small volumes of peripheral blood serum. Egyptian Journal of Medical Human Genetics 2018; 19(3): 221-3.
- Ali AI, Badran YR, Hassuneh MR, Sanber KS, Ismail SI. Effect of Interleukins on Antibody Production by Epstein-Barr Virus Transformed B Cells. Monoclon Antib Immunodiagn Immunother 2015; 34(3): 162-8.
- Sato T, Deiwick A, Raddatz G, Koyama K, Schlitt HJ. Interactions of allogeneic human mononuclear cells in the two-way mixed leucocyte culture (MLC): influence of cell numbers, subpopulations and cyclosporin. Clin Exp Immuno 1999; 115(2): 301-8.
- Fan Y, Naglich JG, Koenitzer JD, Ribeiro H, Lippy J, Blum J, et al. Miniaturized High-Throughput Multiparameter Flow Cytometry Assays Measuring In Vitro Human Dendritic Cell Maturation and T-Cell Activation in Mixed Lymphocyte Reactions. SLAS Discov 2018; 23(7): 742-50.
- Flores C, Fouquet G, Moura IC, Maciel TT, Hermine O. Lessons to Learn From Low-Dose Cyclosporin-A: A New Approach for Unexpected Clinical Applications. Front Immunol 2019; 10: 588.
- Tay C, Kanellakis P, Hosseini H, Cao A, Toh BH, Bobik A, Kyaw T. B Cell and CD4 T Cell Interactions Promote Development of Atherosclerosis. Front Immunol 2020; 10: 3046.
- Fei F, Yu Y, Schmitt A, Rojewski MT, Chen B, Gotz M, et al. The inhibitory effect of cyclosporine a and prednisolone on both cytotoxic cd8+ T cells and cd4+ cd25+ regulatory T cells. Current Signal Transduction Therapy 2009; 4(3): 222-33.
- Zimmerer JM, Pham TA, Wright CL, Tobin KJ, Sanghavi PB, Elzein SM, et al. Alloprimed CD8(+) T
cells regulate alloantibody and eliminate alloprimed B cells through perforin- and FasL-dependent mechanisms. Am J Transplant 2014; 14(2): 295-304.
- Pasha RP, Roohi A, Shokri F. Establishment of human heterohybridoma and lymphoblastoid cell lines specific for the Rh D and C antigens. Transfus Med 2003; 13(2): 83-92.
- Golestani R, Pourfathollah AA, Moazzeni SM. An extreme strategy for the production of hybridoma. Hybridoma (Larchmt) 2009; 28(2): 139-44.
- Funaro A, Gribaudo G, Luganini A, Ortolan E, Lo Buono N, Vicenzi E, et al. Generation of potent neutralizing human monoclonal antibodies against cytomegalovirus infection from immune B cells. BMC Biotechnol 2008; 8: 85.
- Moens L, Tangye SG. Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage. Front Immunol 2014; 5: 65.
|
Sci J Iran Blood Transfus Organ 2021;18(2): 97-104
|
Alloimmune lymphocytes proliferation in presence
of Mixed Lymphocyte Culture and cyclosporine
Milani S.1, Yari F.1
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
Abstract
Background and Objectives
Mixed Lymphocytes Culture (MLC), is a method studies the cell-cell interaction between subpopulations of lymphocytes and the production of compounds caused by this interaction. MLC as a source of cytokines can increase B lymphocytes proliferation. Repeated blood transfusions cause B lymphocytes alloimmunization. Cyclosporin A has inhibitory effect on immune system. In alloimmunization, stimulated B lymphocytes can produce antibodies against exposed foreign red blood cell antigens. Immortalization of B lymphocytes can lead to continuous production of monoclonal antibodies. Considering MLC as an important source of cytokines and the presence of B lymphocytes as a group of cells in peripheral blood cells, the aim of this study was to produce MLC and evaluate its effect on proliferation of alloimmune peripheral blood cells in the presence or absence of cyclosporine A using microscopic evaluation and dye exclusion staining method.
Materials and Methods
In an experimental study, RhD antigen positive and negative lymphocytes were exposed together for MLC production. Peripheral blood lymphocytes resulted from two alloimmunized patients was treated with MLC and cyclosporine, and their proliferation was analyzed compared to the control group using microscopy and trypan blue staining method. The results were analyzed by t-test using prism software (p< 0.05).
Results
MLC and cyclosporine increased proliferation of lymphocytes with mean value being 440000 (SD: 197989.8) vs 160000 (SD: 84852.8) of control group.
Conclusions
MLC and cyclosporine increase lymphocyte cells proliferation. By confirmation of additional experiments, MLC and cyclosporine may be used as effective agents in lymphocyte proliferation and antibody production of alloimmune B lymphocytes.
Key words: Cyclosporin A, Lymphocyte Culture test٬ Mixed, Blood Transfusion
Received: 10 May 2021
Accepted: 30 May 2021
Correspondence: Milani S., PhD of Medical Biotechnology. Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine.
P.O.Box: 14665-1157, Tehran, Iran. Tel: (+9821) 88993778; Fax: (+9821) 88993778
E-mail:s.milani@tmi.ac.ir
|
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
|
|
.jpg)
.png)
